logo
Select company
Select metric
-74.67Interest Coverage
VS
Market
8
Sector
21
Industry
33
History
23
$ 0.8Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information

Ticker

CUE

Company Name

CUE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CUE BIOPHARMA INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CUE - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ -38.38M$ 514K-74.67
3/31/2025$ -39.9M$ 684K-58.33
12/31/2024$ -39.88M$ 796K-50.1
9/30/2024$ -43.46M$ 1.15M-37.76
6/30/2024$ -45.71M$ 1.25M-36.6
3/31/2024$ -48.7M$ 1.27M-38.47
12/31/2023$ -49.49M$ 1.25M-39.75
9/30/2023$ -50.64M$ 1.25M-40.62
6/30/2023$ -50.76M$ 1.08M-46.79
3/31/2023$ -50.81M$ 1.06M-47.98
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CUE BIOPHARMA INC's latest trailing twelve months (TTM) Int. Coverage stands at 0.
  • Over the past 5 years, CUE BIOPHARMA INC's average Int. Coverage has been -192.69.
  • The median Int. Coverage for CUE BIOPHARMA INC during this period was -49.04
  • CUE BIOPHARMA INC reached its highest Int. Coverage over the past 5 years at -36.6.
  • The lowest Int. Coverage recorded by CUE BIOPHARMA INC in the same timeframe -1.82K

CUE BIOPHARMA INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
OVID : OVID THERAPEUTICS INC -VERU : VERU INC -188.9PSTV : PLUS THERAPEUTICS INC -4.11CRVO : CERVOMED INC -SRZN : SURROZEN INC -TCRX : TSCAN THERAPEUTICS INC -42.98CBUS : CIBUS INC -7.06FATE : FATE THERAPEUTICS INC -ALGS : ALIGOS THERAPEUTICS INC -4.97PYXS : PYXIS ONCOLOGY INC -

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for CUE BIOPHARMA INC is calculated as follows: EBIT [ $ -42.6M ] / Int. Exp. [ $ 0 ]
(=) Int. Coverage [ 0 ]

CUE - Interest Coverage, Last 5 years

-1.82K

Minimum

Mar 31, 2022

-36.6

Maximum

Jun 30, 2024

-192.69

Average

-49.04

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.16 with a standard deviation of 8.41.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.36K
min-25.4
max28.75
average2.16
median2.09
std8.41